Article info

Download PDFPDF

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

Authors

  1. Correspondence to Dr Mark D Lyttle; mark.lyttle{at}uhbristol.nhs.uk
View Full Text

Citation

Lyttle MD, Bielicki JA, Barratt S, et al
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

Publication history

  • Received February 17, 2019
  • Revised March 8, 2019
  • Accepted March 14, 2019
  • First published May 22, 2019.
Online issue publication 
February 20, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.